Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine

被引：34
作者：
Yin, Ji-Ye [1 ,2 ,3 ]
Li, Xi [1 ,2 ,3 ]
Zhou, Hong-Hao [1 ,2 ,3 ]
Liu, Zhao-Qian [1 ,2 ,3 ]
机构：
[1] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China
[3] Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Peoples R China
来源：
PHARMACOGENOMICS | 2016年 / 17卷 / 12期
关键词：
chemotherapy sensitivity; NSCLC; pharmacogenomics; platinum; polymorphism; precision medicine; SNP; CELL LUNG-CANCER; SINGLE-NUCLEOTIDE POLYMORPHISMS; REPAIR GENE POLYMORPHISMS; REDUCTASE C677T POLYMORPHISM; DNA-REPAIR; CLINICAL-OUTCOMES; TREATMENT RESPONSE; 1ST-LINE PLATINUM; PREDICTIVE-VALUE; CHINESE PATIENTS;
D O I：
10.2217/pgs-2016-0074
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Lung cancer is one of the leading causes of cancer-related death in the world. Platinum based chemotherapy is the first-line treatment for non-small-cell lung cancer (NSCLC), however, the therapeutic efficiency varies remarkably among individuals. A large number of pharmacogenomics studies aimed to identify genetic variations which can be used to predict platinum response. Those studies are leading NSCLC treatment to the new era of precision medicine. In the current review, we provided a comprehensive update on the main recent findings of genetic variations which can be used to predict platinum sensitivity in the NSCLC patients.
引用
收藏
页码：1365 / 1378
页数：14
相关论文
共 136 条
[21]   Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population [J].
Hong, Wei ;
Wang, Kai ;
Zhang, Yi-ping ;
Kou, Jun-yan ;
Hong, Dan ;
Su, Dan ;
Mao, Wei-min ;
Yu, Xin-min ;
Xie, Fa-jun ;
Wang, Xiao-jian .
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2013, 14 (03) :207-215
[22]   Correlation between thymidylate synthase gene polymorphisms and efficacy of pemetrexed in advanced non-small cell lung cancer [J].
Hu, Qiong ;
Li, Xuefei ;
Su, Chunxia ;
Chen, Xiaoxia ;
Gao, Guanghui ;
Zhang, Jie ;
Zhao, Yinmin ;
Li, Jiayu ;
Zhou, Caicun .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (06) :1010-1016
[23]   Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies [J].
Huang, Dongning ;
Zhou, Yang .
BIOMEDICAL REPORTS, 2014, 2 (04) :452-462
[24]   Two Novel Functional Single Nucleotide Polymorphisms of ADRB3 Are Associated With Type 2 Diabetes in the Chinese Population [J].
Huang, Qiong ;
Yang, Tian-Lun ;
Tang, Bei-Sha ;
Chen, Xiang ;
Huang, Xi ;
Luo, Xiang-Hang ;
Zhu, Yuan-Shan ;
Chen, Xiao-Ping ;
Hu, Ping-Cheng ;
Chen, Juan ;
Wei, Wei ;
Zhou, Hong-Hao ;
Yin, Ji-Ye ;
Liu, Zhao-Qian .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07) :E1272-E1277
[25]   Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach [J].
Huang, R. Stephanie ;
Duan, Shiwei ;
Shukla, Sunita J. ;
Kistner, Emily O. ;
Clark, Tyson A. ;
Chen, Tina X. ;
Schweitzer, Anthony C. ;
Blume, John E. ;
Dolan, M. Eileen .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) :427-437
[26]   Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer [J].
Huang, Shao-jun ;
Wang, Yu-fei ;
Jin, Zhi-yong ;
Sun, Jia-yang ;
Guo, Zhan-lin .
TUMOR BIOLOGY, 2014, 35 (05) :4023-4029
[27]   Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer [J].
Isla, D ;
Sarries, C ;
Rosell, R ;
Alonso, G ;
Domine, M ;
Taron, M ;
Lopez-Vivanco, G ;
Camps, C ;
Botia, M ;
Nuñez, L ;
Sanchez-Ronco, M ;
Sanchez, JJ ;
Lopez-Brea, M ;
Barneto, I ;
Paredes, A ;
Medina, B ;
Artal, A ;
Lianes, P .
ANNALS OF ONCOLOGY, 2004, 15 (08) :1194-1203
[28]   The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer [J].
Jiang, You-Hua ;
Xu, Xiao-Ling ;
Ruan, Hai-Hong ;
Xu, Wei-Zhen ;
Li, Dan ;
Feng, Jian-Guo ;
Han, Qian-Bo ;
Mao, Wei-Min .
MEDICAL ONCOLOGY, 2014, 31 (05)
[29]   Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer [J].
Jin, Z. Y. ;
Zhao, X. T. ;
Zhang, L. N. ;
Wang, Y. ;
Yue, W. T. ;
Xu, S. F. .
GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) :7617-7625
[30]   Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy A Prospective Clinical Study [J].
Joerger, Markus ;
Burgers, Sjaak A. ;
Baas, Paul ;
Smit, Egbert F. ;
Haitjema, Tjeerd J. ;
Bard, Martin P. L. ;
Doodeman, Valerie D. ;
Smits, Paul H. M. ;
Vincent, Andrew ;
Huitema, Alwin D. R. ;
Beijnen, Jos H. ;
Schellens, Jan H. M. .
CANCER, 2012, 118 (09) :2466-2475
12345678910